PRKACA: the catalytic subunit of protein kinase A and adrenocortical tumors
Cyclic-AMP (cAMP)-dependent protein kinase (PKA) is the main effector of cAMP signaling in all tissues. Inactivating mutations of the PRKAR1A gene, coding for the type 1A regulatory subunit of PKA, are responsible for Carney complex and primary pigmented nodular adrenocortical disease (PPNAD). PRKAR...
Main Authors: | Annabel Sophie Berthon, Eva eSzarek, Constantine eStratakis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-05-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fcell.2015.00026/full |
Similar Items
-
Evaluation of Protein Kinase cAMP-Activated Catalytic Subunit Alpha as a Therapeutic Target for Fibrolamellar Carcinoma
by: Stefanie S. Schalm, et al.
Published: (2023-01-01) -
ACTH-independent Cushing's syndrome due to bilateral adrenocortical adenoma: A case report
by: Majd Sharaf, MD candidate, et al.
Published: (2021-11-01) -
Novel insights into the genetic and pathophysiology of adrenocortical tumors
by: Ludivine eDrougat, et al.
Published: (2015-06-01) -
Fibrolamellar Carcinoma with DNAJB1-PRKACA Fusion in a 16-Year-Old: Case Report and Review of Literature
by: Varsha Prakash, et al.
Published: (2022-07-01) -
Adrenal hyperplasias in childhood: An update
by: Georgia Pitsava, et al.
Published: (2022-08-01)